The GHIT Fund has awarded a grant of ~$4.5m to Fluxus for developing an ultrasensitive point-of-care (POC) urine test for ...

Following in the footsteps of several pharma companies, life sciences giant Thermo Fisher is doubling down on investments at ...

CEO Gary Guthart quelled concerns of reflexive pricing, with production and manufacturing optimisation a priority instead.

Roche has introduced its Chest Pain Triage algorithm, which is designed to rapidly identify acute coronary syndrome (ACS).

BD has received 510(k) clearance from the FDA for the Phasix ST Umbilical Hernia Patch, enabling the launch of the product ...

Epiminder has received FDA authorisation through the De Novo classification for its implantable continuous EEG monitoring ...

Semiconductors are used in half of all medical devices, with impending tariffs on their import likely to impact the US ...

Novocure has obtained CE Mark approval for its Optune Lua device to treat adults with metastatic non-small cell lung cancer ...

BD has introduced the HemoSphere Alta platform, incorporating predictive algorithms based on AI to manage instability in ...

Biolinq has secured $100m in Series C funds to support the regulatory approval process in the US to launch its intradermal ...

ARUP Laboratories has introduced a blood test for phosphorylated tau 217 to aid in diagnosing the pathology of Alzheimer's ...

Contraception for women has seen little change over the past 50 years, with the most prevalent contraceptive pills containing ...